Preclinical studies for cell transplantation: Isolation of primate fetal hepatocytes, their cryopreservation, and efficient retroviral transduction

被引:13
作者
Andreoletti, M
Pages, JC
Mahieu, D
Loux, N
Farge, D
Sacquin, P
Simon, L
Hamza, J
Bargy, F
Briand, P
Leperq, J
Weber, A
机构
[1] HOP COCHIN,ICGM,INSERM U380,F-75014 PARIS,FRANCE
[2] HOP ST VINCENT DE PAUL,UNITE MED FOETALE,F-75014 PARIS,FRANCE
关键词
D O I
10.1089/hum.1997.8.3-267
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Fetal hepatocytes are an attractive target for in utero cellular transplantation. Their use could provide a very efficient way for implanting normal or transduced cells into the Livers of affected fetuses. Marking cells with recombinant retroviruses is a powerful tool for evaluating the chimerism of grafted animals. The technique relies on the ex vivo transduction efficiency of the engrafted cells. We have isolated fetal primary hepatocytes from nonhuman primates. The cells were cultured and transduced with a retroviral vector carrying the Escherichia coli beta-galactosidase gene. Optimal gene transfer efficiency was obtained 48-60 hr after plating and was as high as 90%. Cryopreservation had little effect on cell viability and infectivity: The viability of thawed hepatocytes remained high (75-85%) and the infection efficiency was identical to that of freshly isolated cells. Efficient ex vivo retroviral gene transfer into fetal hepatocytes provides an appropriate system for testing allogenic grafting and for modifying immunogenicity of engrafted cells. These results open up new perspectives for cell transplantation through cell banking.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 29 条
[11]   A PILOT-STUDY OF EX-VIVO GENE-THERAPY FOR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].
GROSSMAN, M ;
RADER, DJ ;
MULLER, DWM ;
KOLANSKY, DM ;
KOZARSKY, K ;
CLARK, BJ ;
STEIN, EA ;
LUPIEN, PJ ;
BREWER, HB ;
RAPER, SE ;
WILSON, JM .
NATURE MEDICINE, 1995, 1 (11) :1148-1154
[12]   ISOENZYME SHIFT IN CULTURED FETAL HUMAN HEPATOCYTES - A STUDY OF PYRUVATE-KINASE AND PHOSPHOFRUCTOKINASE [J].
GUGUENGUILLOUZO, C ;
MARIE, J ;
COTTREAU, D ;
PASDELOUP, N ;
KAHN, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 93 (02) :528-534
[13]  
GUPTA S, 1995, HUM GENE THER, V5, P955
[14]  
HOSHI H, 1987, IN VITRO CELL DEV B, V23, P723
[15]   ENGRAFTMENT OF GENE-MODIFIED UMBILICAL-CORD BLOOD-CELLS IN NEONATES WITH ADENOSINE-DEAMINASE DEFICIENCY [J].
KOHN, DB ;
WEINBERG, KI ;
NOLTA, JA ;
HEISS, LN ;
LENARSKY, C ;
CROOKS, GM ;
HANLEY, ME ;
ANNETT, G ;
BROOKS, JS ;
ELKHOUREIY, A ;
LAWRENCE, K ;
WELLS, S ;
MOEN, RC ;
BASTIAN, J ;
WILLIAMSHERMAN, DE ;
ELDER, M ;
WARA, D ;
BOWEN, T ;
HERSHFIELD, MS ;
MULLEN, CA ;
BLAESE, RM ;
PARKMAN, R .
NATURE MEDICINE, 1995, 1 (10) :1017-1023
[16]   ADENOVIRAL-MEDIATED GENE-TRANSFER TO FETAL PULMONARY EPITHELIA IN-VITRO AND IN-VIVO [J].
MCCRAY, PB ;
ARMSTRONG, K ;
ZABNER, J ;
MILLER, DW ;
KORETZKY, GA ;
COUTURE, L ;
ROBILLARD, JE ;
SMITH, AE ;
WELSH, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2620-2632
[17]   Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I [J].
Overturf, K ;
AlDhalimy, M ;
Tanguay, R ;
Brantly, M ;
Ou, CN ;
Finegold, M ;
Grompe, M .
NATURE GENETICS, 1996, 12 (03) :266-273
[18]  
PAGES JC, 1995, GENE THER, V2, P547
[19]   EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO PRIMARY CULTURE OF MURINE AND HUMAN HEPATOCYTES - EXPRESSION OF THE LDL RECEPTOR [J].
PAGES, JC ;
ANDREOLETTI, M ;
BENNOUN, M ;
VONS, C ;
ELCHEROTH, J ;
LEHN, P ;
HOUSSIN, D ;
CHAPMAN, J ;
BRIAND, P ;
BENAROUS, R ;
FRANCO, D ;
WEBER, A .
HUMAN GENE THERAPY, 1995, 6 (01) :21-30
[20]  
PITT BR, 1995, GENE THER, V2, P344